Ad
related to: pictures of sickle cell patients at risk for infection care- What Is LYFGENIA?
Learn About LYFGENIA As
A Treatment Option.
- Find A QTC
Start Your Search For A Qualified
Treatment Center Nearest You.
- Steps To Treatment
See A Breakdown Of
Treatment With LYFGENIA.
- FAQs
Your LYFGENIA Questions. Answered.
Review Patient Information.
- What Is LYFGENIA?
Search results
Results From The WOW.Com Content Network
Sickle cell disease (SCD), also simply called sickle cell, is a group of hemoglobin-related blood disorders typically inherited. [2] The most common type is known as sickle cell anemia. [2] It results in an abnormality in the oxygen-carrying protein haemoglobin found in red blood cells. [2] This leads to the red blood cells adopting an abnormal ...
A study published in 2013 found that patients seeking care from 2003 through 2008 at an ER for their sickle cell crises experienced 50% longer wait times than patients who arrived at ERs with ...
Hematology. Sickle cell trait describes a condition in which a person has one abnormal allele of the hemoglobin beta gene (is heterozygous), but does not display the severe symptoms of sickle cell disease that occur in a person who has two copies of that allele (is homozygous). Those who are heterozygous for the sickle cell allele produce both ...
One of the drugmakers, Bluebird Bio, in August cut its forecast for use of all three of its gene therapy products this year to 85 at most, down from 105. Earlier this week, it said 10 patients had ...
The mother of a teenager with sickle cell disease said medical treatment for the genetic blood disorder was a "postcode lottery". Nathan, 16, from Northampton, suffers from chronic pain and takes ...
Anthony Clifford Allison (21 August 1925 – 20 February 2014) was a South African geneticist and medical scientist who made pioneering studies on the genetic resistance to malaria. [2] Allison undertook his primary schooling in Kenya, completed his higher education in South Africa, and obtained a BSc in medical science from the University of ...
Acute chest syndrome. The acute chest syndrome is a vaso-occlusive crisis of the pulmonary vasculature commonly seen in people with sickle cell anemia. This condition commonly manifests with a new opacification of the lung (s) on a chest x-ray. [1]
Other standard care for sickle cell patients have been chemotherapy drug hydroxyurea, or once-daily drugs such as Pfizer's Oxbryta, which aim to slow the breakdown of red blood cells.